Diapositive 1 - Québec International

Transcription

Diapositive 1 - Québec International
Au front contre les maladies
infectieuses et immunitaires
Marc Ouellette, Ph.D. , FRSC, FCAHS
Chaire de Recherche du Canada sur la
résistance antimicrobienne
Centre Recherche en Infectiologie
CHU- Québec et Université Laval
Conférence- Des succès Inspirants
Québec International- Université Laval
31 Janvier 2013
Marc Ouellette- CV
DES, Collège St-Alexandre Limbour, 1973-78
DEC, Cegep de l’Outaouais, 1978-80
B.Sc., Université d’Ottawa, 1980-83
Ph.D., Université Laval, 1983-87
Stagiaire, Institut Pasteur, 2005 (6 mois)
Post-doc, Netherlands Cancer Institute, 1987-90
Université Laval, CHUL, CHUQ, CHU-Québec, 1990Directeur Scientifique, IMII-IRSC, 2010-
1983-1990
Sequencing – from man to machine
1990-2010
Mentors and collaborators
Ph.D. :
Stage :
Post-doc:
Paul H. Roy
Patrice Courvalin
Piet Borst
CIHR Group on Leishmania
Barbara Papadopoulou, Michel J. Tremblay, Jacques Corbeil, Martin Olivier
Alternative to Antimicrobials
Diagnostics: Michel G. Bergeron;
Bacteriocins : Ismael Fliss;
Drug resistance in Leishmania
USA, Canada
India
Colombie, Brésil
France, Espagne
Iran
Phages: Sylvain Moineau;
Microbiome
Antibiotic resistance
Canada
Research Associate
Danielle Légaré
Philippe Leprohon
Post-docs
Barbara Papadopoulou,
Jingyu Wang,
Christhop Kündig,
Ajay K. Singh
Denis Sereno
Jolyne Drummelsmith
Hafid Soualhine
Benjamin Gourbal
Aude Foucher
Baptiste Vergnes
Larbi Dridi
Jean Michel Ubeda
Jie Feng
Angana Mukherjee
Adriano Coelho
Dewan Billal
Jean-François Ritt
Bédis Dridi
Élodie Gazanion
Isabel Vincent
Rubens do Monte Neto
Graduate students
Research assistants
Danielle Légaré,
Gaétan Roy
Katherine Grondin,
Suzanne Avoine
Anass Haimeur,
Marie Plourde
Eric Leblanc,
Hélène Gingras
Christian Brochu,
Chantal Guimond,
2000-2008
Amal El Fadili,
Nadine Messier
Dave Richard
Vicky Brochu
Paul-André Genest,
Isabel Girard
François Ménard,
Nathalie Trudel
Philippe Leprohon
Guylaine Briand
Karima El Fadili
Maxime Laverdière
Dominic Gagnon
Patrick Boucher
Nathalie Marquis
Amin Ahmed-Ouameur,
Wilfried Moreira,
Marie-Christine Brotherton
Fereshteh Fani,
Nuno Santarem,
Andréanne Lupien
Marie-Claude Laffitte
Marie-Michelle Genois
Renaud Pétry
Jessica El Khoury
1st cycle : 20
7 of them did graduate work
in the lab
Visiting scientists
Dennis Doijes
Iris Segura
Javier Perez Victoria
Ramtin Hadighi
Angana Mukherjee
Nuno Santarem
Adriano Coelho
Rubens Domonte
Jolien Pingnet
Valter Andrade Neto
John Walker
Chris Carter
Madhubala Rentala
Tom Seebeek
Laurence Lachaud
19 pays différents
2010-20xx
CIHR investments in III related work
CIHR- reform
III-Road map signature Initiatives
III- Strategic Initiatives
III- new strategic plan
III Strategic Priorities 2007-12
Emerging Infections and Microbial Resistance:
Solutions from innovation in tools and technologies
HIV/AIDS: From prevention and therapy to addressing
global health challenges
Immunotherapy: New approaches through systems
biology
Pandemic Influenza Preparedness: Prevention,
therapy and public health challenges
Vaccines of the 21st Century: Integrating innate and
adaptive immunity and novel vaccine technologies
THE III STRATEGIC PLAN FOR 2013-2018
Two overarching strategic directions
Strengthening and coordinating infection and immunity research
Ensuring Application and Impact of Research
Two broad priority research areas
Priority Research Area 1: Preparing for and responding to emerging threats
emerging microbial pathogens
antimicrobial resistance
vaccine development
improved diagnostics
Priority Research Area 2: Integrating I&I knowledge in
Prevention and Control of Chronic Disease
inflammation
human microbiome
transplantation
human immunology and immunotherapy
environmental threats
HIV/AIDS and Hepatitis C
Initiatives pilotées par l’IMII
Ongoing Initiatives
Clinical Autoimmunity
Novel Alternatives to Antibiotics
Canada UK Partnership on Antibiotic Resistance
Canadian Microbiome Initiative (RSI- intersect with ICDI)
Network catalyst
Meeting Planning and Dissemination (MPDs)
Federal Initiatives under the leadership of III
Pandemic Preparedness Strategic Research Initiative (PPSRI), PCIRN
Hepatitis C Research Initiative
HIV Initiatives
Upcoming Initiatives
Inflammation in Chronic Disease- RSI
Transplantation – RSI (lead) –intersect with ICDI
Personalized Medicine- RSI
Cure HIV
Pathways to Health Equity –RSI
Evidence Informed Health care- RSI
Vaccines CHVI, ISTP-MOST
Translational initiative on AMR
Institut des Maladies Infectieuses et Immunitaires
OBIS
Judith Bray; assistant director
Diane Christin; project officer
Wendy Street; associate
HIV
Jennifer Gunning; associate director
Suzette Dos Santos, associate
Jane Hutchinson, associate
Simone Marcantonio, project officer
QBIS
Serge Desnoyers; assistant director
Jennifer Raven, associate
Mireille Perrault, executive assistant